Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis

Thailand is encountering challenges to introduce the high-cost sofosbuvir for chronic hepatitis C treatment as part of the Universal Health Care’s benefit package. This study was conducted in respond to policy demand from the Thai government to assess the value for money and budget impact of introdu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattanavipapong, Waranya, Anothaisintawee, Thunyarat, Teerawattananon, Yot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821370/
https://www.ncbi.nlm.nih.gov/pubmed/29466415
http://dx.doi.org/10.1371/journal.pone.0193112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821370/
https://www.ncbi.nlm.nih.gov/pubmed/29466415
http://dx.doi.org/10.1371/journal.pone.0193112

Ejemplares similares